[Anti-aquaporin 4-antibody detection system]

Area of Science:

• Neuroimmunology
• Clinical Neurology
• Pathophysiology

Context:

• Optic-spinal multiple sclerosis (OSMS) and neuromyelitis optica (NMO) are debilitating neurological conditions.
• Accurate diagnosis and understanding of disease mechanisms are crucial for effective patient management.
• Previous diagnostic criteria for OSMS/NMO lacked specificity, particularly in Japanese populations.

Purpose:

• To investigate the epidemiological and clinicopathological characteristics of Japanese patients diagnosed with OSMS/NMO.
• To develop and validate sensitive assays for detecting anti-aquaporin-4 (AQP4) antibodies and NMO-IgG.
• To correlate the presence and levels of anti-AQP4 antibodies with clinical disease activity and lesion distribution.

Summary:

• A large cohort of Japanese patients previously diagnosed with OSMS/NMO was tested for anti-AQP4 antibodies using newly developed assays.
• Nearly 70% of patients with extensive spinal cord lesions tested positive for the anti-AQP4 antibody.
• Antibody-positive patients exhibited distinct features: higher prevalence in females, increased blindness, more frequent relapses, and a higher incidence of cerebral lesions on MRI.

Impact:

• This study establishes a strong association between anti-AQP4 antibody seropositivity and OSMS/NMO in Japan, refining diagnostic criteria.
• The findings highlight the role of anti-AQP4 antibodies in the pathogenesis of OSMS/NMO, particularly concerning AQP4-rich areas.
• Understanding the antibody's role provides insights into disease activity and potential therapeutic targets for OSMS/NMO.